EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Low-Cost Insulin Pump with Predictive-Based Mitigation of Hyperglycemia and Hypoglycemia

Robele Megu, Surafel Belay, Biruk Gebiba, Dawit Assefa

Journal of Biomedical Engineering Systems and Technologies for LMICs · 07.02.2026 · 1 (1)

DOI: 10.64510/t3jwsb23 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biomedical Engineering Systems and Technologies for LMICs, online erschienen am 07.02.2026. Verfasst von Robele Megu und 3 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Equitable access to insulin pumps, the gold standard for diabetes management, remains elusive in low- and middle-income countries (LMICs). For example, in countries like Ethiopia, fewer than 1% of insulin-dependent patients access this technology, hindered by prohibitive pricing and regulatory complexities. The current study proposes a low-cost insulin pump integrating custom-made hardware design with predictive software algorithms. The proposed design features a micro control unit (MCU) within a threaded spindle-based mechanical framework, housed in a 3D-printed casing. A complete prototype using an Arduino microcontroller has been developed, and testing was conducted using a vision-based syringe displacement method. Novel contributions of this design include a Kalman filter algorithm for hypoglycemia prediction, Bluetooth-enabled Android app control, and automation software delivering personalized insulin doses. This design significantly lowers the total cost of production, with material costs alone reduced to USD $95, while achieving accuracy approaching that of commercial pumps (84.7% of basal doses within ±5%) and a 3.49% average infusion error. By leveraging custom PCB and mechanical designs, it bridges frugal engineering with clinical functionality, offering scalability potential through local manufacturing. Future steps involve conducting IEC-aligned safety testing and benchmarking against commercial pumps (e.g., Medtronic 640G) to validate real-world performance. This innovation demonstrates a pathway to democratize advanced diabetes care in LMICs, combining cost-effectiveness (projected retail price of USD $285– $475, assuming 3 to 5 times the bill of materials cost - BoM) with regulatory-compliant safety. It has the potential to reduce complications and improve outcomes in resource-constrained settings.

Zitieren

APA

Megu, R., Belay, S., Gebiba, B., & Assefa, D. (2026). Low-Cost Insulin Pump with Predictive-Based Mitigation of Hyperglycemia and Hypoglycemia. Journal of Biomedical Engineering Systems and Technologies for LMICs, 1(1). https://doi.org/10.64510/t3jwsb23

Vancouver

Megu R, Belay S, Gebiba B, Assefa D. Low-Cost Insulin Pump with Predictive-Based Mitigation of Hyperglycemia and Hypoglycemia. Journal of Biomedical Engineering Systems and Technologies for LMICs. 2026;1(1). doi:10.64510/t3jwsb23

BibTeX
@article{Megu2026,
  author = {Megu, Robele and Belay, Surafel and Gebiba, Biruk and Assefa, Dawit},
  title = {Low-Cost Insulin Pump with Predictive-Based Mitigation of Hyperglycemia and Hypoglycemia},
  journal = {Journal of Biomedical Engineering Systems and Technologies for LMICs},
  year = {2026},
  volume = {1},
  number = {1},
  doi = {10.64510/t3jwsb23}
}
Kostenlos starten →